Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
Clinical trial NCT01992107 · COMPLETED
Trial details
- NCT number
- NCT01992107
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-08-01
- Enrollment
- 2333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.